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  Despite the existence of an active vaccination program, 
recently  emerged  strains  of  nephropathogenic  infectious 
b r o n c h i t i s  v i r u s  ( I B V )  i n  K o rea  have  caused  significant 
economic losses in the poultry industry. In this study, we 
assessed the pathogenic and antigenic characteristics of a 
K-IIb type field strain of IBV that emerged in Korea since 
2003, such as Kr/Q43/06. Specific pathogen free 1-week- 
old  chickens  exhibited  severe  respiratory  symptoms 
(dyspnea) and nephropathogenic lesions (swollen kidneys 
with nephritis and urate deposits) following challenge with 
the recent IBV field strain. The antigenic relatedness (R 
value), based on a calculated virus neutralization index, of 
the K-IIb type field strain and K-IIa type strain KM91 
(isolated  in  1991)  was  30%,  which  indicated  that  the 
recent  strain,  Kr/Q43/06,  is  a  new  variant  that  is  anti-
genically  distinct  from  strain  KM91.  This  report  is  the 
first to document the emergence of a new antigenic variant 
of nephropathogenic IBV in chicken from Korea.
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Introduction 
Infectious bronchitis (IB), caused by the infectious 
bronchitis virus (IBV), is a highly contagious viral disease 
of chickens with a worldwide distribution [4]. It is 
characterized by respiratory symptoms, nephritis, poor 
performance and reduced egg reproduction [4]. 
Despite extensive vaccination, IB has been a perpetual 
problem in the Korean poultry industry since the disease 
was first reported in 1986 [7,9-11,16,17]. Recently, 
phylogenetic analysis revealed that Korean field isolates of 
IBV constitute at least three distinct phylogenetic types: 
K-I, K-II and K-III [10]. K-I type strains are native viruses 
associated with localized incidence in Korea, K-II type 
strains are closely related to nephropathogenic IBV strains 
isolated in China [19], and K-III type strains are closely 
related to enteric IBV variants of Chinese strains. In 
particular, the K-II type nephropathogenic IBV is 
associated with a high mortality rate, and has been the 
source of great economic losses in the poultry industry in 
Korea, despite the availability of a vaccine based on the 
KM91 strain of Korean nephropathogenic IBV [7, 
9-11,17]. 
Molecular epidemiological evidence suggests that K-II 
type QX-like viruses (K-IIb type) isolated since 2003 form 
a different cluster than those (K-IIa type) isolated prior to 
2003 (e.g., strain KM91) [10]. Nevertheless, antigenic 
differences between K-IIa and K-IIb type viruses have yet 
to be fully investigated. 
The purpose of this study was to investigate the 
pathogenic and antigenic characteristics of K-IIb type IBV 
strains currently circulating in Korea to determine whether 
available IBV vaccines based on K-IIa type strains will 
confer cross-protection against field IBV strains. Two 
Korean IBV strains, KM91 and Kr/Q43/06 (National 
Veterinary Research and Quarantine Service, Korea), were 
analyzed. Strain KM91 is a nephropathogenic K-IIa type 
virus that was isolated in early 1990s, and strain Kr/Q43/06 
is a K-IIb type virus isolated in 2006 [10]. The H120 
vaccine strain was used as a reference. 
The pathogenicity of IBV strain Kr/Q43/06 was determined 
using specific pathogen free (SPF) 1-week-old layer type 
chickens (Lohmann, Germany). Ten chickens were 
inoculated with IBV Kr/Q43/06 (10
5.7 EID50/dose) by eye 
drop inoculation. Five birds that served as the inoculation 
control group were inoculated with phosphate buffered 
saline. All birds were maintained in isolators with negative 
pressure and monitored daily for 14 days for overt clinical 
symptoms (depression, respiratory signs, diarrhea, etc.) 
and mortality. Six days post inoculation (dpi), all of the 
birds in the IBV group started to exhibit mild respiratory 
symptoms, including sneezing and rales. Clinical signs 
became more severe by 10 dpi, when most of the affected 358    Kang-Seuk Choi et al.
Table 1. Virus neutralization index (NI) for infectious bronchitis 
virus (IBV) strains Kr/Q43/06 and KM91
Antiserum
Virus strains
Kr/Q43/06 KM91 H120
Kr/Q43/06 6.2* 2.5 0.8 
KM91 1.4 6.2 0.8 
H120 1.2 2.0 3.8
*NI was determined using the alpha method and SPF embryonated
chicken eggs, and represents the log10 difference in titer between 
virus alone and virus-antiserum mixtures.
Table 2. Antigenic relatedness (R value) (%) of KIIa and KIIb 
type strains of IBV 
Anti-serum
Virus strains
Kr/Q43/06 KM91 H120
Kr/Q43/06 100*
KM91 30 100
H120 20 26 100
NI values in Table 1. R = 70∼100%, same serotype; R = 33∼
70%, different subtype (minor); R = 11∼32%, different subtype
(major);  R = 0∼10%, different serotype. *R values were 
calculated using the method [1].
birds (7/10) exhibited severe depression and dyspnea, 
which continued to progress until the end of the experiment 
(14 dpi). Birds in the control group showed no clinical 
signs of IBV infection throughout the experimental period. 
In the infected birds, gross lesions were mainly confined 
to the kidney, which was pale, swollen with interstitial 
nephritis and showed evidence of severe urate deposition. 
IBV was recovered from the trachea (90%, or 9/10) and 
kidney (80%, or 8/10) of infected birds by inoculating 
tissue homogenate into the allantoic cavity of 9 to 11 
day-old SPF embryonated chicken eggs (Lohmann, 
Germany) using standard methods [5] and identified by 
dot-immunoblotting assay using monoclonal antibodies 
[17]. Control birds exhibited no pathological lesions in the 
kidney, and no evidence of viral load. These results 
demonstrated that strain Kr/Q43/06 is nephropathogenic in 
chickens. 
Cross virus neutralization tests were performed using 
anti-sera against strains KM91, Kr/Q43/06 and H120 to 
determine the antigenic relationship between Kr/Q43/06 
and KM91. IBV anti-sera were raised in our laboratory 
according to the immunization protocol of Gelb et al [5]. 
Anti-sera against homologous virus were used by 
checkerboard titration. Cross-virus neutralization tests 
were performed using SPF embryonated chicken eggs and 
the alpha method, as previously described [18]. Briefly, 
Serial dilutions of IBV are incubated with a standard 
dilution of serum (1/5 dilution), and then the serum-virus 
mixtures in each dilution were incubated into 5 SPF 
embryonated chicken eggs. Eggs were also inoculated with 
the corresponding titers of virus alone in parallel. 
End-points were calculated by the Reed and Muench 
method [15]. A neutralization index (NI) was calculated, 
representing the difference (in logarithmic units) in viral 
titer between virus alone and the corresponding virus- 
antiserum mixture. An NI value of ＞4.5 indicated 
homologous strains, a value of 1.5∼4.5 indicated 
heterologous strains, and a value of ＜1.5 was considered 
a different serotype. As shown in Table 1, strain Kr/Q43/06 
was effectively neutralized by antiserum to the homologous 
strain (NI of 6.2). However, the NI for antisera to strains 
KM91 and H120 was 1.4 and 1.2, respectively, which 
indicated that antisera to strains KM91 and H120 were 
unable to effectively neutralize strain Kr/Q43/06. NI 
values were converted to antigenic relatedness (R value) 
using the following formula created by Archetti and 
Horsfall [1]: 
√ R =  r1 × r2
where r1 is the ratio of the NI value of virus 2 in the 
presence of antiserum to virus 1 (heterologous NI value) to 
the NI value of virus 1 in the presence of antiserum to virus 
1 (homologous NI value); r2 is the ratio of the heterologous 
NI value of virus 1 to the homologous NI value of virus 2; 
and R defines the antigenic relatedness of the two viruses. 
For assessing the similarity of the two viruses, we used the 
criteria of Brooksby [3], as follows: an R value of 100% or 
close to 100% indicated antigenic identity between the two 
tested viruses; an R value ＞70% indicated little or no 
difference between the two viruses tested; an R value 
between 33% and 70% indicated a minor subtype 
difference; an R value between 11% and 32% indicated a 
major subtype difference; and an R value between 0% and 
10% indicated different serotypes. The R value for strains 
Kr/Q43/06 and KM91 was 30%, which indicated that 
nephropathogenic strain Kr/Q43/06 is distantly related to 
strain KM91 (Table 2). Thus, strain Kr/Q43/06 represents 
a new variant that is antigenically distinct from strain 
KM91. To our knowledge, this is the first report of a new 
antigenic variant of nephropathogenic IBV in chickens 
from Korea. 
In a previous study, phylogenetic analyses showed that 
type K-IIb IBV isolates are more closely related to strain 
QX than the K-IIa type strain KM91 at the level of the New variant of Korean nephropathogenic IBV    359
hyper-variable region of the S1 gene of IBV [10]. It is 
worth noting that the QX-like IBV is distributed worldwide, 
including in the Far East of Russia, Italy, the Netherlands, 
the United Kingdom and Japan [2,6,8,13,14]. Thus, K-IIb 
type strains of IBV might have emerged in Korea as a result 
of introduction from foreign countries rather than through 
immune pressure due to vaccination in the field, or 
recombination between field viruses. However, it remains 
unclear how this variant emerged in Korea. Interestingly, 
during viral surveillance in 2003 in Quangdong, China, a 
nephropathogenic strain of IBV was isolated from an 
asymptomatic teal (Anas) of the order Anseriformes [12]. 
This observation raises the possibility of widespread 
dissemination of IBV by wild birds, such as wild migratory 
ducks, as proposed by Bochkov et al [2]. While the role of 
wild birds in trans-boundary transmission of IBV has not 
been demonstrated, additional viral surveillance studies of 
wild birds, particularly wild ducks, are needed. In vivo 
cross protection studies should also be considered to 
determine whether currently available K-IIa type or Mass 
type IBV vaccines confer cross-protection against new 
K-IIb type variants. If currently available IBV vaccines do 
not provide cross-protection against new variant strains 
that emerge in the field, the development of alternative 
vaccines should be considered for the effective control of 
IB in Korea. 
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